NLA Resources
Knowledge Center
Membership Resources
Join the National Lipid Association, focused on enhancing the science and practice of lipidology to promote optimal cardiometabolic health.
After making your filter selections, please scroll down to see results.
The Lipid Panel – Update on LDL-lowering Medications
Risk of Dementia
S5E1: A Focused Update to the 2019 NLA Scientific Statement On The Use of Lp(a) in Clinical Practice
Alan Brown, MD, FACC, MNLA talks with Christie Ballantyne, MD, FNLA about the publication of “A Focused Update to the 2019 NLA Scientific Statement On…
Obesity, dyslipidemia, and cardiovascular disease: A joint expert review from the Obesity Medicine Association and the National Lipid Association
Obesity, dyslipidemia, and cardiovascular disease: A joint expert review from the Obesity Medicine Association and the National Lipid Association
Diabesity
Case Study: Incident Type 2 Diabetes Mellitus following Statin Initiation in Youth
The association of statin use, and incident type 2 diabetes (T2D) is well established in adults. Similar observations have not been reported in youth. Despite…
Dyslipidemia Management in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
Nonalcoholic fatty liver disease (NAFLD) is the accumulation of hepatic fat in ≥ 5% of hepatocytes in the absence of other etiologies of liver disease….